Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-235775, 333-254089 and 333-260066) and Form S-8 (File Nos. 333-228821, 333-231717, 333-263543 and 333-266789) of DiaMedica Therapeutics Inc. of our report dated March 28, 2023, relating to the consolidated financial statements of DiaMedica Therapeutics Inc., which appears in this annual report on Form 10-K for the fiscal year ended December 31, 2022.

 

/s/ Baker Tilly US, LLP

 

Minneapolis, Minnesota

March 28, 2023